Abstract:Key PointsNitric oxide (NO) is a gaseous signalling molecule that is involved in the regulation of the cardiovascular, immune and nervous systems.In the CNS, NO is involved in many processes, including the regulation of synaptic plasticity, the sleep–wake cycle, neurosecretion, fluid balance and reproductive processes. In the PNS, NO is an inhibitory neurotransmitter that mediates the non-adrenergic, non-cholinergic relaxation of smooth muscle in both the gastrointestinal and urogenital tracts.NO exerts its effect on an array of functions through the activation of several intracellular signalling pathways. One key pathway is the soluble guanylyl cyclase–cyclic GMP–protein kinase G system.Physiological amounts of NO are neuroprotective, owing to S-nitrosylation of NMDA (N-methyl-D-aspartate) receptor subunits or of the active sites of caspases. Furthermore, NO activates Akt and CREB (cyclic AMP-responsive-element-binding protein), which are involved in two important survival pathways. NO also induces haem oxygenase 1, a key enzyme in the cellular stress response.If it is produced in excess, or if a cell is under conditions of oxidative stress, NO becomes noxious and may undergo an oxidative–reductive reaction to form toxic compounds known as reactive nitrogen species (RNS), which cause cell damage. Both NO and RNS have a pathogenetic role in the onset and development of neurodegenerative disorders.Although drugs that act on the NO–cGMP pathway are commonly used to treat impotence, lung diseases and pulmonary hypertension, their use for the prevention of neurodegenerative disorders is unlikely. The use of natural antioxidants, such as polyphenols, has been proposed for the prevention or treatment of Alzheimer's disease because of their in vitro ability to counteract NO-induced damage. However, the pharmacokinetics of these substances may limit their use in humans, and so more effort would be required to make these natural substances efficient in the treatment of neurodegenerative disorders.

Nitric Oxide Regulates Exocytosis by S-Nitrosylation of N-ethylmaleimide-Sensitive Factor

Regulation of Vascular Function by Nitric Oxide-Related S-nitrosylation

Nitrergic modulation of ion channel function in regulating neuronal excitability

Exocytosis of endothelial cells is regulated by N-ethylmaleimide-sensitive factor.

Nitric oxide-mediated posttranslational modifications control neurotransmitter release by modulating complexin farnesylation and enhancing its clamping ability

Regulation of the Ischemia-Induced Autophagy-Lysosome Processes by Nitrosative Stress in Endothelial Cells.

Regulatory Role of Nitric Oxide in Cutaneous Inflammation

S-Nitrosylation: An Emerging Paradigm of Redox Signaling

Nitric oxide signaling in health and disease

Exogenous, but not Endogenous Nitric Oxide Inhibits Adhesion Molecule Expression in Human Endothelial Cells

Transcriptome analysis in various cell lines exposed to nitric oxide

Nitric Oxide: News from Stem Cells to Platelets

Nitric oxide: Regulation and function in neutrophil immune responses

Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity

[Regulation of Unfolded Protein Response via Protein S-nitrosylation]

S-Nitrosylation-Mediated Reduction of CaV1.2 Surface Expression and Open Probability Underlies Attenuated Vasoconstriction Induced by Nitric Oxide

Nitric Oxide as a Pro-apoptotic as well as Anti-apoptotic Modulator

Nitric Oxide and S-Nitrosylation in Cardiac Regulation: G Protein-Coupled Receptor Kinase-2 and β-Arrestins as Targets

Inhibition of Interleukin-12 P40 Transcription and NF-κB Activation by Nitric Oxide in Murine Macrophages and Dendritic Cells*

Posttranslational S-nitrosylation modification regulates HMGB1 secretion and promotes its proinflammatory and neurodegenerative effects

Nitric oxide inhibits excitatory vagal afferent input to nucleus tractus solitarius neurons in anaesthetized rats